samedi 4 juillet 2020


PAREXEL and Meiji Pharmaceutical University Announce Academic Program to Develop Japan’s Biopharmaceutical Workforce

Par Rédaction , dans Communiqués , le 9 avril 2018

Monday, April 9th 2018 at 1:00pm UTC

Joint Program for Clinical Research and Clinical Trial Management to
be offered through the PAREXEL Academy

BOSTON & TOKYO–(BUSINESS WIRE)– PAREXEL International Corporation, the world’s leading innovator of
biopharmaceutical services, and Meiji Pharmaceutical University (MPU), a
private pharmacy and science university, today announced a new Joint
Program for Clinical Research and Clinical Trial Management for
undergraduate students. The academic program will offer MPU students an
accredited, four-week course designed to prepare them for careers in the
biopharmaceutical industry.

Designed to meet the growing demands of biopharmaceutical companies
conducting clinical research both inside and outside of Japan, the
collaborative program combines PAREXEL’s global clinical research
expertise with MPU’s established pharmaceutical training experience. All
classes will be conducted in English from PAREXEL Academy lecturers and
are consistent with current global clinical trial standards and
practices. Following a series of two-week pilot programs, the first
official program will be offered in November 2019. In addition, select
MPU students may be eligible for enrollment at the PAREXEL Academy in
Berlin in the future.

“Pharmaceutical research and development expenditures in Japan have
nearly doubled since 20001. With the number of Japanese
students going overseas for education on the decline, this creates an
opportunity for the younger generation to play an active role in
clinical research,” said Shogo Nakamori, Corporate Vice President,
Asia-Pacific and General Manager, PAREXEL Japan. “This program will
leverage PAREXEL’s expertise and MPU’s strong educational foundation to
ensure students receive the necessary training to succeed in the global
pharmaceutical industry of the future.”

“One of our educational goals is to cultivate internationally accepted
pharmacists who are both well-trained and compassionate,” said Keitaro
Ishii, President of Meiji Pharmaceutical University. “We go beyond
preparing students for their required national exams to help them
cultivate their interests in a variety of clinical fields. This program
provides students the valuable opportunity to learn English while
studying the practical operations needed for a career in clinical
research.”

For more than a decade, the PAREXEL Academy has designed and implemented
a wide range of learning programs in clinical research for students in
Asia, Europe, and the United States. PAREXEL’s collaboration with MPU is
the company’s second academic program in Japan, following PAREXEL’s
first program with Kyoto Pharmaceutical University which launched in
early 2016. Since PAREXEL Academy’s inception, approximately 5,000
students have graduated from its programs.

PAREXEL established operations in Japan in 1995 and has more than 1,300
employees based in Tokyo, Kobe and Osaka. The Company provides clinical
research services, consulting and technology offerings to
biopharmaceutical companies.

About PAREXEL International

PAREXEL International Corporation is the world’s leading innovator of
biopharmaceutical services. We simplify our clients’ journey of
transforming scientific discoveries into new medical treatments for
patients with high-quality Phase I-IV clinical research, regulatory,
consulting and market access services. PAREXEL develops breakthrough
innovations and solutions by leveraging its comprehensive therapeutic,
technical and functional expertise, in more than 100 countries around
the world. For more information visit www.PAREXEL.com.

PAREXEL and PAREXEL Informatics are trademarks or registered trademarks
of PAREXEL International Corporation or its affiliates. All other
trademarks are the property of their respective owners.

About Meiji Pharmaceutical University

Meiji Pharmaceutical University (MPU) established the Department of
Pharmacy (6 year course) and the Department of Life and Pharmaceutical
Sciences (4 year course) to respond to the recent rapid change of the
healthcare environment, in which medical techniques have been highly
progressive and the skills of professional pharmacists has improved. The
educational goal of the Department of Pharmacy and Health Sciences is to
educate high-quality pharmacists who can meet the needs of society for
the safe use of pharmaceutical products and for the advancements of
medical technology. New graduates of the university have maintained a
high success rate in the National Exam for Pharmacists. In addition,
with a consistently high job placement rate, the university is high in
the ranks of the top pharmaceutical schools in Japan. MPU offers a
unique training program comprised of seven courses, which aims to
cultivate advanced professional skills, define the students’ career
paths, and enable them to use these skills in the pharmaceutical
profession. As the flagship university, MPU is committed to leading
pharmacy education and holding the responsibility to train highly
professional leaders in various fields of health care and pharmacy,
including distinguished pharmacists, researchers or experts of drug
discovery and life sciences. http://www.my-pharm.ac.jp/.

1 JPMA Data Book 2017; “Report on the Survey of Research and
Development,” Ministry of Internal Affairs and Communications

Contacts

PAREXEL Contacts:
Wendy Ryan (U.S.)
Tel.: +1
781-434-5104
Email: Wendy.Ryan@PAREXEL.com
or
Satoko
Okubo (Japan)
Tel.: +81-3-3537-5090
Email: Satoko.Okubo@PAREXEL.com
or
Meiji
Pharmaceutical University Contact:

Hiroshi Goto
Public
Relations, General Affairs Department,
Tel.: +81-42-495-8615
Email:
Hiro@My-pharm.ac.jp

Source: PAREXEL International

Étiquettes :